INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")
Latest Factsheet and Blog
IBT's factsheet for the month ended 31 October 2024 is now available directly via its web page. Please click here, then 'latest factsheet'.
Obesity has long been a significant global health challenge, particularly in the western world, due to the implications it can have for associated conditions such as heart disease, diabetes and certain cancers. Until recently, treatments focused on lifestyle changes and pharmacological interventions like appetite suppressants and fat absorption inhibitors. However, these early drugs often had limited efficacy and significant side effects, leading to a persistent demand for more effective solutions. Here, we explore the continued innovation taking place in the obesity medication space.
The blog can be read here:
https://www.schroders.com/en-gb/uk/individual/content/the-future-of-obesity/
To sign up for IBT updates by email, please click here.
ENDS
Enquiries:
| Schroder Investment Management Limited
Kirsty Preston (PR)
Kerry Higgins (Company Secretary) |
020 7658 6000
020 7658 6000
| | |
|
Kaso Legg Communications (Financial PR)
Charles Gorman Henry Taylor Effie Aye Maung Hider |
| | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
